Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 4.1% - What's Next?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report)'s stock price traded down 4.1% during mid-day trading on Friday . The company traded as low as $17.07 and last traded at $17.17. 27,653 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 214,375 shares. The stock had previously closed at $17.90.

Analyst Ratings Changes

Several research firms have commented on KMTS. Wells Fargo & Company assumed coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They issued an "overweight" rating and a $28.00 price objective on the stock. The Goldman Sachs Group decreased their price objective on shares of Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating for the company in a research report on Wednesday, April 16th. Wolfe Research initiated coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They issued an "outperform" rating and a $29.00 price target for the company. Bank of America initiated coverage on Kestra Medical Technologies in a report on Monday, March 31st. They issued a "buy" rating and a $30.00 price target for the company. Finally, Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a report on Monday, March 31st. They issued a "buy" rating and a $28.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $27.50.

Kestra Medical Technologies Stock Down 6.2%

The stock has a 50 day moving average of $21.26.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last posted its quarterly earnings data on Monday, April 14th. The company reported ($1.25) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.61). During the same quarter in the previous year, the business earned ($1.18) earnings per share.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of KMTS. Ghisallo Capital Management LLC acquired a new stake in shares of Kestra Medical Technologies in the first quarter valued at approximately $1,869,000. Armistice Capital LLC acquired a new position in shares of Kestra Medical Technologies in the 1st quarter worth approximately $312,000. Quarry LP purchased a new position in shares of Kestra Medical Technologies during the 1st quarter worth approximately $33,000. Omega Fund Management LLC acquired a new stake in Kestra Medical Technologies in the 1st quarter valued at approximately $44,754,000. Finally, T. Rowe Price Investment Management Inc. purchased a new stake in Kestra Medical Technologies in the first quarter valued at approximately $56,613,000.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.